Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific

Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth trends in the near term. Going forward, the Asia Pacific EP mapping and ablation device market will expand rapidly, supported by rising AF treatment volumes, an expanding patient pool, improving access to healthcare, and the emergence of newer, premium-priced devices, although cost constraints and a challenging reimbursement environment will hinder the pace of market expansion to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in Asia Pacific from 2019 through 2032.

The COVID-19 pandemic has had a significant short-term impact on the EP mapping and ablation device market.

How has the COVID-19 pandemic affected procedure volumes?

How quickly will procedure volumes recover?

What impact will the pandemic have on market dynamics?

Demographic, reimbursement, and regulatory factors differ by country, resulting in varying market landscapes.

Which countries will present the greatest opportunity for manufacturers, and why?

How are regulatory changes impacting the Asia Pacific EP mapping and ablation device markets?

What difficulties will manufacturers need to overcome in order to be successful in each country?

The expanding EP diagnostic and ablation catheter segments offer growth opportunities.

Which factors are driving growth in the EP catheter markets?

How does device reuse impact the EP catheter markets in the Asia Pacific region?

Catheter ablation for AF continues to be a focus among electrophysiologists.

How fast are AF treatment volumes changing, and how does AF treatment volume growth compare to other arrhythmia types?

What are the factors driving growth in AF treatment volumes?

New technologies—such as pulsed field ablation—will enter the market in the coming years.

What technologies will enter the market going forward, and when are they expected to be launched?

How will the uptake of new devices affect pricing trends and revenue growth?

Which new competitors could enter the market? How is their technology differentiated from what is available today?

Cost sensitivity and device reusability continue to affect Latin American EP mapping and ablation device market growth.

How does device reuse impact the EP catheter market in Latin America?

Which catheters are reused and what effect does device reuse have on market revenues?

How will device reuse trends change over the forecast period?

Table of contents

Electrophysiology Mapping and Ablation Devices - Market Insights - Asia Pacific

Dhananjay S Raja

Dhananjay Raja is an associate healthcare research and data analyst in the Cardiovascular Medtech Insights team at Clarivate, specializing in the interventional oncology and electrophysiology mapping and ablation device markets. Dhananjay holds a Bachelor’s degree in Chemistry from Shiv Nadar University and is currently pursuing a second Bachelor’s degree in Data Science and Programming at the Indian Institute of Technology, Madras.

Contact sales Login to access report

Back to all Medtech Insights reports